SCHEMBL2232638

SCHEMBL2232638

O=Cc1c(O)c2ccccc2oc1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
ALDH1A1 P00352 10/20 0.58
MAPT P10636 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HPGD P15428 3/20 0.58
MAOB P27338 2/20 0.58
MAOA P21397 1/20 0.58
ALOX12 P18054 1/20 0.58
CA12 O43570 1/20 0.58
CA9 Q16790 1/20 0.58
NQO1 P15559 2/20 0.57
TP53 P04637 2/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
ABCB11 O95342 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23728392 0.84 KDM4E (0.62) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL15842324 0.83 KDM4E (0.56) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL29379994 0.79 KDM4E (0.69) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL7737431 0.79 KDM4E (0.69) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL29872 0.79 KDM4E (0.69) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL13417538 0.79 KDM4E (0.54) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL27799769 0.79 GAA (0.65) KDM4EALDH1A1MAPTSMN1; SMN2NQO1
SCHEMBL5273182 0.79 CA9 (0.53) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL24864750 0.78 NPSR1 (0.46) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL8701572 0.77 KDM4E (0.67) KDM4EALDH1A1MAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-108603148-B Powdery detergent composition for clothing having stable fragrance component 长谷川香料株式会社 2021-06-29 CN disclosed
CN-106008435-A Fluorescence-enhanced fluorescent probe for detection of Au<3+> and preparation method thereof 华南理工大学 2016-10-12 CN disclosed
US-20110263642-A1 METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS FIBROGEN, INC. (US) 2011-10-27 US disclosed
EP-2341904-A1 METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS Fibrogen, Inc. (US) 2011-07-13 EP disclosed
WO-2010024908-A1 METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS FIBROGEN, INC. (US) 2010-03-04 WO disclosed
US-4237286-A COLORING PLASTICS AND LACQUERS IN YELLOW TO RED SHADES CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237292-A SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237293-A COLORFAST SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4154741-A Process for the manufacture of pyrono-condensed coumarins CIBA-GEIGY CORPORATION (US) 1979-05-15 US disclosed
US-4144258-A ORGANIC PIGMENTS FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1979-03-13 US disclosed
US-4132708-A Metal complexes of azomethines and process for their manufacture CIBA-GEIGY CORPORATION (US) 1979-01-02 US disclosed
US-4111947-A DYES, PLASTICS, LACQUERS CIBA-GEIGY CORPORATION (US) 1978-09-05 US disclosed
US-4065481-A 1:1-Azomethine-metal-complex dyestuffs CIBA-GEIGY CORPORATION (US) 1977-12-27 US disclosed
US-4024132-A Azomethine pigments CIBA-GEIGY CORPORATION (US) 1977-05-17 US disclosed
US-4022770-A COLORING CIBA-GEIGY CORPORATION (US) 1977-05-10 US disclosed
US-4016157-A COLORING PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1977-04-05 US disclosed
US-3988323-A PIGMENTS CIBA-GEIGY CORPORATION (US) 1976-10-26 US disclosed
US-3974149-A TONERS CIBA-GEIGY CORPORATION (US) 1976-08-10 US disclosed
US-3963708-A Bis-azomethine metal complex colorants from hydroxycoumarin derivatives or hydroxychromone derivatives CIBA-GEIGY CORPORATION (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263642-A1 METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS PMP22, MAG, NEFM KDM4E 2831/4885ALDH1A1 2881/4885MAPT 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.